missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human TRAIL/TNFSF10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
£380.12
Specifications
Gene ID (Entrez) | 8743 |
---|---|
Molecular Weight (g/mol) | 21 kDa (monomer) |
Name | TRAIL/TNFSF10 |
Quantity | 10μg |
Source | Mouse myeloma cell line,NS0-derived human TRAIL/TNFSF10 protein Thr95-Gly281,with an N-terminal Met and 6-His tag |
Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
18325637
|
R&D Systems™
375-TL-010/CF |
£380.12
10µg |
Estimated Shipment: 08-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
18176760
|
R&D Systems™
375-TL-010 |
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. |
£380.12
10µg |
Estimated Shipment: 08-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
Description
The Recombinant Human TRAIL/TNFSF10 Protein is derived from NS0. The Recombinant Human TRAIL/TNFSF10 Protein has been validated for the following applications: Bioactivity.Specifications
8743 | |
TRAIL/TNFSF10 | |
Mouse myeloma cell line,NS0-derived human TRAIL/TNFSF10 protein Thr95-Gly281,with an N-terminal Met and 6-His tag | |
Noncovalently-linked homotrimer and disulfide-linked homodimer | |
Recombinant |
21 kDa (monomer) | |
10μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |